41 studies found for:    " April 16, 2008":" May 16, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Qualitative and Quantitative HIV RNA Detection in Saliva Using the Oragene RNA Kit
Condition: HIV Infections
Intervention:
22 Completed
Has Results
Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection
Conditions: HIV Infections;   Hepatitis B
Interventions: Drug: Entecavir with continued standard of care antiretroviral therapy;   Drug: continued standard of care with tenofovir in addition to emtricitabine or lamivudine
23 Completed Impact of Peer Health Workers and Mobile Phones on HIV Care
Condition: HIV Infections
Interventions: Behavioral: Peer Health Workers Intervention;   Behavioral: Peer Health Workers and Mobile Phone Intervention
24 Completed
Has Results
Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 Patients
Condition: HIV Infections
Intervention: Drug: raltegravir
25 Unknown  Enhancing Communication and HIV Outcomes
Condition: HIV Infections
Intervention: Behavioral: communication training
26 Completed Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)
Conditions: Hepatitis B;   HIV Infection
Intervention: Biological: GenHevac-B
27 Completed CCRC: A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Raltegravir Therapy
Conditions: HIV Infections;   AIDS
Interventions: Procedure: Upper Endoscopy and biopsies;   Drug: raltegravir;   Drug: efavirenz
28 Completed Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)
Condition: HIV Infections
Intervention: Drug: Lopinavir/ritonavir
29 Completed An Open Label Treatment Protocol to Provide Continued Elvucitabine Treatment
Condition: HIV Infections
Intervention: Drug: elvucitabine
30 Completed A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP
Condition: HIV Infections
Intervention: Drug: AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP
31 Unknown  Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone
Conditions: HIV Infections;   HIV-Associated Lipodystrophy Syndrome
Intervention:
32 Terminated Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive Patients
Conditions: Atherosclerosis;   HIV Infections
Interventions: Drug: Rosuvastatin;   Drug: Placebo
33 Completed Study of Provider Computer Alerts Designed to Improve Delivery of HIV Care
Condition: HIV Infections
Interventions: Other: Standard (static) Computer Alerts;   Other: Enhanced Computer Alerts
34 Completed Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand
Condition: HIV Infections
Interventions: Drug: GPO-Vir Z30 tablet;   Drug: Lamivudine;   Drug: Nevirapine;   Drug: Zidovudine
35 Completed Effectiveness of Community-Level Behavioral and Biomedical Interventions for Reducing HIV/STIs in Men in Peru
Conditions: HIV Infections;   Sexually Transmitted Infections
Interventions: Behavioral: Enhanced Partner Therapy (EPT);   Behavioral: Communidades Positivas (CPOS);   Behavioral: Standard Care
36 Active, not recruiting Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Conditions: HIV Infections;   Hyperlipidemia
Intervention: Drug: Atorvastatin
37 Completed The Influence of Raltegravir on Pravastatin Pharmacokinetics(GRAPPA)
Condition: HIV Infections
Interventions: Drug: Pravastatin;   Drug: Raltegravir;   Drug: Pravastatin and raltegravir
38 Suspended Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort
Condition: HIV Infections
Interventions: Drug: Ibandronate;   Behavioral: Lifestyle modifications
39 Completed Aging & HIV/AIDS Neurocognitive Sequelae and Functional Consequences
Condition: HIV Infections
Intervention:
40 Completed
Has Results
TMC125-TiDP35-C213: Safety and Antiviral Activity of Etravirine (TMC125) in Treatment-Experienced, HIV Infected Children and Adolescents
Condition: HIV-1
Interventions: Drug: Etravirine (TMC125);   Drug: Optimized background regimen (OBR)

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-41) Show next page of results
Indicates status has not been verified in more than two years